Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

Fig. 2

The workflow of the study. GBM: Glioblastoma multiforme; IMRT: Intensity-modulated radiation therapy; HSRT: Hypofractionated stereotactic radiotherapy; MRI: magnetic resonance imaging; MRS: magnetic resonance spectroscopy; PET: positron emission tomography

Back to article page